Home/Filings/4/0001077183-22-000055
4//SEC Filing

Sholehvar David 4

Accession 0001077183-22-000055

CIK 0001077183other

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 7:07 PM ET

Size

6.9 KB

Accession

0001077183-22-000055

Insider Transaction Report

Form 4
Period: 2022-04-01
Sholehvar David
President, Clinical Services
Transactions
  • Award

    Common Stock

    2022-04-01+30,86430,864 total
  • Award

    Stock Option (Right to Buy)

    2022-04-01+66,37266,372 total
    Exercise: $12.15Exp: 2029-04-01Common Stock (66,372 underlying)
Footnotes (2)
  • [F1]On April 1, 2022, Dr. Sholehvar was granted 30,864 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.
  • [F2]On April 1, 2022, Dr. Sholehvar was granted 66,372 stock options. These options vest ratably over the first four anniversary dates of the grant date.

Issuer

NEOGENOMICS INC

CIK 0001077183

Entity typeother

Related Parties

1
  • filerCIK 0001916426

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 7:07 PM ET
Size
6.9 KB